ASMase is Essential for the Immune Response to Partial-Tumor Radiation Exposure
Cellular Physiology and Biochemistry · 2024
DOI: 10.33594/000000726 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cellular Physiology and Biochemistry, 2024. Verfasst von Mickael Mathieu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Research Unit, Emile Roux Hospital Center, Le Puy-en-Velay, France. Hauptthemen laut MEDLINE: Sphingomyelin Phosphodiesterase, Mice, Inbred C57BL, Carcinoma, Lewis Lung, Intercellular Adhesion Molecule-1. Die Arbeit wurde bisher 2-mal zitiert (Crossref).
Abstract (Originalsprache)
Background/Aims: Tumor response to radiation is thought to depend on the direct killing of tumor cells. Our laboratory has called this into question. Firstly, we showed that the biology of the host, specifically the endothelial expression of acid sphingomyelinase (ASMase), was critical in determining tumor radiocurability. Secondly, we have shown that the immune system can enhance radiation response by allowing a complete tumor control in hemi-irradiated tumors. In this paper, we focus on the integration of these two findings.
Methods
We used Lewis Lung Carcinoma (LLC) cells, injected in the flank of either: (i) ASMase knockout or (ii) WT of matched background (sv129xBl/6) or (iii) C57Bl/6 mice. Radiation therapy (RT) was delivered to 50% or 100% of the LLC tumor volume. Tumor response, immune infiltration (CD8+ T cells), ICAM-1, and STING activation were measured. Radiotherapy was also combined with methyl-cyclodextrin, to inhibit the ASMase-mediated formation of ceramide-enriched lipid rafts.
Results
We recapitulated our previous finding, namely that tumor hemi-irradiation was sufficient for tumor control in the LLC/C57Bl/6 model. However, in ASMase KO mice hemi-irradiation was ineffective. Likewise, pharmacological inhibition of ASMase significantly reduced the tumor response to hemi-irradiation. Further, we demonstrated elevated ICAM-1 expression, increased levels of CD8+ T cells, ICAM-1, and STING activation in tumors growing in C57Bl/6 mice, as well as the ASMase WT strain. However, no such changes were seen in tumors growing in ASMase KO mice.
Conclusion
ASMase and ceramide generation are necessary to mediate a radiation-induced anti-tumor immune response via STING activation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinical Research Unit, Emile Roux Hospital Center, Le Puy-en-Velay, France.
- Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York City, NY, USA.
- Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York City, NY, USA.
- Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York City, NY, USA, haimovia@mskcc.org.
Zitieren
APA
Mathieu, M., Nepali, P. R., Russell, J., Askarifirouzjaei, H., Baltaci, M., Powell, S. N., Humm, J., Deasy, J. O., & Haimovitz-Friedman, A. (2024). ASMase is Essential for the Immune Response to Partial-Tumor Radiation Exposure. Cellular Physiology and Biochemistry. https://doi.org/10.33594/000000726
Vancouver
Mathieu M, Nepali PR, Russell J, Askarifirouzjaei H, Baltaci M, Powell SN, et al. ASMase is Essential for the Immune Response to Partial-Tumor Radiation Exposure. Cellular Physiology and Biochemistry. 2024. doi:10.33594/000000726
BibTeX
@article{Mathieu2024,
author = {Mathieu, Mickael and Nepali, Prerna R and Russell, James and Askarifirouzjaei, Hadi and Baltaci, Melis and Powell, Simon N and Humm, John and Deasy, Joseph O and Haimovitz-Friedman, Adriana},
title = {ASMase is Essential for the Immune Response to Partial-Tumor Radiation Exposure},
journal = {Cellular Physiology and Biochemistry},
year = {2024},
doi = {10.33594/000000726}
}
EUVIMED